Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma

Published:2024-03 Issue: Volume:73 Page:101054
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Kim Yuna,Jung Kwan-Young,Kim Yun Hak,Xu Pan,Kang Baeki E.,Jo Yunju,Pandit Navin,Kwon Jeongho,Gariani Karim,Gariani Joanna,Lee Junguee,Verbeek Jef,Nam Seungyoon,Bae Sung-Jin,Ha Ki-Tae,Yi Hyon-Seung,Shong Minho,Kim Kyun-Hwan,Kim Doyoun,Jung Hee Jung,Lee Chang-Woo,Kim Kwang Rok,Schoonjans Kristina,Auwerx Johan,Ryu Dongryeol

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Korea Ministry of Science and ICT

Ministry of Trade, Industry and Energy

Ministry of Science, ICT and Future Planning

European Research Council

Ministry of Health and Welfare

National Research Foundation of Korea

École Polytechnique Fédérale de Lausanne

Korea Drug Development Fund

Publisher

Elsevier BV